Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Pyelonephritis

Pyelonephritis

Part of Nephritis

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Pyelonephritis

5 trials tracked for Pyelonephritis: 3 in phase 3 or 4.

5Trials tracked
3Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 2 Phase 2 2
  1. Phase 4 Management of Sub-Clinical Bacteriuria in Pregnancy Completed
  2. Phase 3 Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) Completed
  3. Phase 3 Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis Completed
  4. Phase 2 MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034) Completed
  5. Phase 2 Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003) Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Sickle cell trait is associated with increased risk of kidney disease, pulmonary embolism, and anemia
Hematology Meta-analysis
Sickle cell trait is associated with increased risk of kidney disease, pulmonary embolism, and anemia Sickle cell trait linked to higher risks of kidney and blood issues
This meta-analysis analyzed 4,813 individuals with sickle cell trait (SCT) to identify phenome-wide and laboratory-wide associations. The st…
New data shows that people with sickle cell trait may face higher risks for kidney disease, anemia, and other serious health conditions.
Oct 2, 2026
Cefepime-nacubactam and aztreonam-nacubactam non-inferior for complicated UTI and pyelonephritis
Infectious Disease RCT
Cefepime-nacubactam and aztreonam-nacubactam non-inferior for complicated UTI and pyelonephritis New antibiotics show promise for complicated urinary tract infections
This phase 3 randomised double-blind study in adults with complicated urinary tract infection or acute uncomplicated pyelonephritis found ce…
A large trial found new antibiotic combinations worked better than standard care for certain urinary infections in adults.
May 16, 2026
Dipstick urinalysis shows high specificity but low sensitivity for UTI in febrile infants under 12 months
Pediatrics Cohort
Dipstick urinalysis shows high specificity but low sensitivity for UTI in febrile infants under 12 months A Simple Strip That Spots UTIs in Babies
A retrospective single-center cohort study of febrile infants aged 0–12 months with suspected UTI evaluated dipstick urinalysis against urin…
A simple bedside urine test can help doctors spot kidney infections in babies under one year, with specificity up to 99 percent when nitrite…
Frontiers Apr 14, 2026